Magenta Therapeutics, Inc.MGTANASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank25
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P25
Within normal range
vs 3Y Ago
-11.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-65.13%
20240.00%
2022-10.87%
20215.63%
2020-7.08%
2019-21.40%
2018-102.59%
2017-266.86%
20160.00%